Journal of International Medical Research (Aug 2020)

Bioavailable testosterone is associated with symptoms of depression in adult men

  • Zhongbao Chen,
  • Xubo Shen,
  • Kunming Tian,
  • Yijun Liu,
  • Shimin Xiong,
  • Qin Yu,
  • Lulu Dai,
  • Yongjun Shi,
  • Renjuan Zhang,
  • Rong Zeng,
  • Qiyou Wan,
  • Chengliang Xiong,
  • Yuanzhong Zhou

DOI
https://doi.org/10.1177/0300060520941715
Journal volume & issue
Vol. 48

Abstract

Read online

Objective This study aimed to determine the relationship between serum testosterone levels and depressive symptoms in an adult male population. Methods We conducted a cross-sectional study of 1166 male participants from Zunyi, Guizhou, China. Each participant completed a questionnaire, a brief clinical exam, and had a fasting blood sample taken. We measured serum testosterone, sex hormone-binding globulin, and luteinizing hormone levels. Multiple linear regression was used to evaluate the effect of demographic factors on the relationship between the depressive symptom score and serum sex hormone levels. Results Mean testosterone, sex hormone-binding globulin, and luteinizing hormone levels were significantly higher in the depressive symptom group than in the non-depressed group. The mean calculated free serum testosterone level and free testosterone index (FTI) were significantly lower in the depressive symptom group than in the non-depressed group. Additionally, the mean FTI was significantly negatively correlated with the Beck Depression Inventory scale score in the multiple linear regression model (95% confidence interval: −3.274 to −0.406). Conclusions Decreased bioactive testosterone levels might be a contributing factor of depression in adult men. The FTI could be the most sensitive biomarker reflecting the level of bioavailable testosterone in patients with depression.